| Title : Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients - Blanco-Silvente_2017_Int.J.Neuropsychopharmacol_20_519 |
| Author(s) : Blanco-Silvente L , Castells X , Saez M , Barcelo MA , Garre-Olmo J , Vilalta-Franch J , Capella D |
| Ref : Int J Neuropsychopharmacol , 20 :519 , 2017 |
| Abstract : Blanco-Silvente_2017_Int.J.Neuropsychopharmacol_20_519 |
| ESTHER : Blanco-Silvente_2017_Int.J.Neuropsychopharmacol_20_519 |
| PubMedSearch : Blanco-Silvente_2017_Int.J.Neuropsychopharmacol_20_519 |
| PubMedID: 28201726 |
Blanco-Silvente L, Castells X, Saez M, Barcelo MA, Garre-Olmo J, Vilalta-Franch J, Capella D (2017)
Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients
Int J Neuropsychopharmacol
20 :519
Blanco-Silvente L, Castells X, Saez M, Barcelo MA, Garre-Olmo J, Vilalta-Franch J, Capella D (2017)
Int J Neuropsychopharmacol
20 :519